Early Serum Infliximab Levels in Pediatric Ulcerative Colitis.

deBruyn, Jennifer C C; Jacobson, Kevan; El-Matary, Wael; Wine, Eytan; Carroll, Matthew W; Goedhart, Caitlin; Panaccione, Remo; Wrobel, Iwona T; Huynh, Hien Q

deBruyn, Jennifer C C; Jacobson, Kevan; El-Matary, Wael; Wine, Eytan; Carroll, Matthew W; Goedhart, Caitlin; Panaccione, Remo; Wrobel, Iwona T; Huynh, Hien Q.

Afiliação

deBruyn JCC; Department of Pediatrics, University of Calgary, Calgary, AB, Canada.
Jacobson K; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.
El-Matary W; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Wine E; Department of Pediatrics, University of Manitoba, Winnipeg, MB, Canada.
Carroll MW; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.
Goedhart C; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.
Panaccione R; Department of Pediatrics, University of Calgary, Calgary, AB, Canada.
Wrobel IT; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.
Huynh HQ; Department of Medicine, University of Calgary, Calgary, AB, Canada.

Front Pediatr ; 9: 668978, 2021.

Article em En | MEDLINE | ID: mdl-34395336

Palavras-chave

induction; infliximab; pediatrics; serum concentration; ulcerative colitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google